Home / Compliance actions / 480724

FDA Warning Letter — Triangle Compounding Pharmacy Inc

Case 480724 — FEI 3004969894

The FDA took a Warning Letter action against Triangle Compounding Pharmacy Inc on November 2, 2015 (Cary, NC). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Triangle Compounding Pharmacy Inc
Date
November 2, 2015
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Cary, NC (United States)

Facility

Recent inspections

  • 1088641 (VAI Thu Apr 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017932 (OAI Thu Jul 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 913701 (OAI Fri Jan 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 896439 (OAI Mon Sep 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 821119 (OAI Fri Mar 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other compliance actions

FDA data resources